Complement use of Chinese herbal medicine after percutaneous coronary intervention: a prospective observational study.

Si-Yu Yan,Wei-Xian Yang,Pei-Pei Lu,Xuan-Tong Guo,Cai-Xia Guo,Yan-Ni Su,Li-Hong Ma

Journal of geriatric cardiology : JGC（2022）

引用 0|浏览3

暂无评分

摘要

For CAD patients after PCI treatment, complement use of Chinese herbal medicine is associated with a lower 2-year MACE incidence. Randomized prospective studies are warranted to provide higher levels of benefit evidence in these patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要